N. Dakhallah, J. Steglich, A. L. Alazraki, S. M. Castellino, K. Dieckmann, J. E. Flerlage, C. Gowdy, M. B. Heneghan, K. M. Kelly, H. A. Lai, C. Mauz-Körholz, K. M. McCarten, S. Milgrom, R. Pabari, M. Palese, S. D. Voss, L. Kurch, D. Stoevesandt, J. Seelisch
{"title":"儿童、青少年和年轻人霍奇金淋巴瘤的影像学缺陷:寻找卡亚尔倡议,以桥梁多学科患者护理","authors":"N. Dakhallah, J. Steglich, A. L. Alazraki, S. M. Castellino, K. Dieckmann, J. E. Flerlage, C. Gowdy, M. B. Heneghan, K. M. Kelly, H. A. Lai, C. Mauz-Körholz, K. M. McCarten, S. Milgrom, R. Pabari, M. Palese, S. D. Voss, L. Kurch, D. Stoevesandt, J. Seelisch","doi":"10.1002/hon.70094_374","DOIUrl":null,"url":null,"abstract":"<p>N. Dakhallah and J. Steglich equally contributing author.</p><p><b>Introduction:</b> Hodgkin lymphoma (HL) is a highly curable malignancy in children, adolescents, and young adults (CAYA), and current treatment strategies aim to minimize adverse late effects. Many patients are enrolled in clinical trials that include centralized review for both initial and interim staging. While academic guidelines provide a structured framework, real-world clinical scenarios sometimes present imaging pitfalls that require nuanced judgment.</p><p><b>Methods</b>: The Staging, Evaluation and Response Criteria (SEARCH) for CAYAHL initiative was established in 2011 to harmonize staging and response criteria in HL in CAYA. However, applying these published criteria can present challenges in situations where imaging pitfalls are encountered. This SEARCH for CAYAHL project is a transatlantic collaboration among experts in diagnostic radiology, nuclear medicine radiology, radiation oncology and pediatric oncology. A working group first identified the most frequent and relevant imaging pitfalls in HL. Through literature review, imaging and clinical experience, and the use of specific real-word cases, this effort defines and describes imaging pitfalls in HL in CAYA.</p><p><b>Results</b>: Morphologic and metabolic imaging pitfalls in HL refer to the misinterpretation of findings that can occur during staging, disease evaluation, or post-treatment surveillance. These radiological findings are not indicative of disease but are rather manifestations of other causes that are specific to each tissue or organ. In this work, we explore pitfalls resulting from suboptimal imaging conditions, concurrent inflammatory, infectious, or other causes. We discuss organ specific pitfalls involving the lymph nodes, lungs, bone, bone marrow, spleen, liver and Waldeyer’s ring and present important considerations on imaging following the completion of therapy.</p><p><b>Conclusions</b>: This collaborative effort aims to disseminate insights gained from decades of centralized review experience in North American and European trials to optimize patient care by integrating imaging and clinical expertise. Although not intended as a comprehensive staging guide, it highlights recurrent imaging pitfalls that may lead to diagnostic uncertainty. By encouraging interdisciplinary exchange, this work seeks to complement existing literature and serve as a troubleshooting guide for situations where clinical realities diverge from academic paradigms, ultimately paving the way for improved patient outcomes.</p><p><b>Keywords:</b> Hodgkin lymphoma (pediatric, adolescent, and young adult)</p><p><b>Potential sources of conflict of interest:</b></p><p><b>C. Mauz-Körholz</b></p><p><b>Employment or leadership position:</b> Institutional research grant Merck</p><p><b>Consultant or advisory role:</b> Merck advisory board</p>","PeriodicalId":12882,"journal":{"name":"Hematological Oncology","volume":"43 S3","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/hon.70094_374","citationCount":"0","resultStr":"{\"title\":\"IMAGING PITFALLS IN PEDIATRIC, ADOLESCENT, AND YOUNG ADULT HODGKIN LYMPHOMA: A SEARCH FOR CAYAHL INITIATIVE TO BRIDGE MULTIDISCIPLINARY PATIENT CARE\",\"authors\":\"N. Dakhallah, J. Steglich, A. L. Alazraki, S. M. Castellino, K. Dieckmann, J. E. Flerlage, C. Gowdy, M. B. Heneghan, K. M. Kelly, H. A. Lai, C. Mauz-Körholz, K. M. McCarten, S. Milgrom, R. Pabari, M. Palese, S. D. Voss, L. Kurch, D. Stoevesandt, J. Seelisch\",\"doi\":\"10.1002/hon.70094_374\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>N. Dakhallah and J. Steglich equally contributing author.</p><p><b>Introduction:</b> Hodgkin lymphoma (HL) is a highly curable malignancy in children, adolescents, and young adults (CAYA), and current treatment strategies aim to minimize adverse late effects. Many patients are enrolled in clinical trials that include centralized review for both initial and interim staging. While academic guidelines provide a structured framework, real-world clinical scenarios sometimes present imaging pitfalls that require nuanced judgment.</p><p><b>Methods</b>: The Staging, Evaluation and Response Criteria (SEARCH) for CAYAHL initiative was established in 2011 to harmonize staging and response criteria in HL in CAYA. However, applying these published criteria can present challenges in situations where imaging pitfalls are encountered. This SEARCH for CAYAHL project is a transatlantic collaboration among experts in diagnostic radiology, nuclear medicine radiology, radiation oncology and pediatric oncology. A working group first identified the most frequent and relevant imaging pitfalls in HL. Through literature review, imaging and clinical experience, and the use of specific real-word cases, this effort defines and describes imaging pitfalls in HL in CAYA.</p><p><b>Results</b>: Morphologic and metabolic imaging pitfalls in HL refer to the misinterpretation of findings that can occur during staging, disease evaluation, or post-treatment surveillance. These radiological findings are not indicative of disease but are rather manifestations of other causes that are specific to each tissue or organ. In this work, we explore pitfalls resulting from suboptimal imaging conditions, concurrent inflammatory, infectious, or other causes. We discuss organ specific pitfalls involving the lymph nodes, lungs, bone, bone marrow, spleen, liver and Waldeyer’s ring and present important considerations on imaging following the completion of therapy.</p><p><b>Conclusions</b>: This collaborative effort aims to disseminate insights gained from decades of centralized review experience in North American and European trials to optimize patient care by integrating imaging and clinical expertise. Although not intended as a comprehensive staging guide, it highlights recurrent imaging pitfalls that may lead to diagnostic uncertainty. By encouraging interdisciplinary exchange, this work seeks to complement existing literature and serve as a troubleshooting guide for situations where clinical realities diverge from academic paradigms, ultimately paving the way for improved patient outcomes.</p><p><b>Keywords:</b> Hodgkin lymphoma (pediatric, adolescent, and young adult)</p><p><b>Potential sources of conflict of interest:</b></p><p><b>C. Mauz-Körholz</b></p><p><b>Employment or leadership position:</b> Institutional research grant Merck</p><p><b>Consultant or advisory role:</b> Merck advisory board</p>\",\"PeriodicalId\":12882,\"journal\":{\"name\":\"Hematological Oncology\",\"volume\":\"43 S3\",\"pages\":\"\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2025-06-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/hon.70094_374\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hematological Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/hon.70094_374\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematological Oncology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/hon.70094_374","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
N. Dakhallah和J. Steglich是同等贡献的作者。霍奇金淋巴瘤(HL)是儿童、青少年和年轻人(CAYA)中一种高度可治愈的恶性肿瘤,目前的治疗策略旨在尽量减少不良的晚期反应。许多患者被纳入临床试验,包括对初始和中期分期的集中审查。虽然学术指南提供了结构化的框架,但现实世界的临床场景有时会出现成像陷阱,需要细致入微的判断。方法:2011年建立了CAYAHL分期、评价和反应标准(SEARCH),以统一CAYAHL HL的分期和反应标准。然而,在遇到成像陷阱的情况下,应用这些已发布的标准可能会带来挑战。这个搜索CAYAHL项目是跨大西洋放射诊断学、核医学放射学、放射肿瘤学和儿科肿瘤学专家之间的合作。一个工作组首先确定了HL中最常见和相关的影像学缺陷。通过文献回顾、影像学和临床经验,以及使用具体的实际病例,本研究定义并描述了CAYA中HL的影像学缺陷。结果:HL的形态学和代谢成像缺陷是指在分期、疾病评估或治疗后监测期间可能出现的对结果的误解。这些放射学检查结果并不表明疾病,而是每个组织或器官特有的其他原因的表现。在这项工作中,我们探讨了由次优成像条件、并发炎症、感染或其他原因引起的陷阱。我们讨论了涉及淋巴结、肺、骨、骨髓、脾、肝和瓦尔德耶氏环的器官特异性陷阱,并提出了治疗完成后影像学的重要考虑因素。结论:这项合作旨在传播从北美和欧洲试验中获得的数十年集中审查经验的见解,通过整合影像学和临床专业知识来优化患者护理。虽然不打算作为一个全面的分期指南,但它强调了可能导致诊断不确定性的复发性影像学缺陷。通过鼓励跨学科的交流,这项工作旨在补充现有的文献,并作为临床现实与学术范式不同的情况的故障排除指南,最终为改善患者的治疗效果铺平道路。关键词:霍奇金淋巴瘤(儿童、青少年和年轻人)潜在的利益冲突来源:C。Mauz-KörholzEmployment或领导职位:机构研究资助默克顾问或顾问角色:默克顾问委员会
IMAGING PITFALLS IN PEDIATRIC, ADOLESCENT, AND YOUNG ADULT HODGKIN LYMPHOMA: A SEARCH FOR CAYAHL INITIATIVE TO BRIDGE MULTIDISCIPLINARY PATIENT CARE
N. Dakhallah and J. Steglich equally contributing author.
Introduction: Hodgkin lymphoma (HL) is a highly curable malignancy in children, adolescents, and young adults (CAYA), and current treatment strategies aim to minimize adverse late effects. Many patients are enrolled in clinical trials that include centralized review for both initial and interim staging. While academic guidelines provide a structured framework, real-world clinical scenarios sometimes present imaging pitfalls that require nuanced judgment.
Methods: The Staging, Evaluation and Response Criteria (SEARCH) for CAYAHL initiative was established in 2011 to harmonize staging and response criteria in HL in CAYA. However, applying these published criteria can present challenges in situations where imaging pitfalls are encountered. This SEARCH for CAYAHL project is a transatlantic collaboration among experts in diagnostic radiology, nuclear medicine radiology, radiation oncology and pediatric oncology. A working group first identified the most frequent and relevant imaging pitfalls in HL. Through literature review, imaging and clinical experience, and the use of specific real-word cases, this effort defines and describes imaging pitfalls in HL in CAYA.
Results: Morphologic and metabolic imaging pitfalls in HL refer to the misinterpretation of findings that can occur during staging, disease evaluation, or post-treatment surveillance. These radiological findings are not indicative of disease but are rather manifestations of other causes that are specific to each tissue or organ. In this work, we explore pitfalls resulting from suboptimal imaging conditions, concurrent inflammatory, infectious, or other causes. We discuss organ specific pitfalls involving the lymph nodes, lungs, bone, bone marrow, spleen, liver and Waldeyer’s ring and present important considerations on imaging following the completion of therapy.
Conclusions: This collaborative effort aims to disseminate insights gained from decades of centralized review experience in North American and European trials to optimize patient care by integrating imaging and clinical expertise. Although not intended as a comprehensive staging guide, it highlights recurrent imaging pitfalls that may lead to diagnostic uncertainty. By encouraging interdisciplinary exchange, this work seeks to complement existing literature and serve as a troubleshooting guide for situations where clinical realities diverge from academic paradigms, ultimately paving the way for improved patient outcomes.
Keywords: Hodgkin lymphoma (pediatric, adolescent, and young adult)
Potential sources of conflict of interest:
C. Mauz-Körholz
Employment or leadership position: Institutional research grant Merck
期刊介绍:
Hematological Oncology considers for publication articles dealing with experimental and clinical aspects of neoplastic diseases of the hemopoietic and lymphoid systems and relevant related matters. Translational studies applying basic science to clinical issues are particularly welcomed. Manuscripts dealing with the following areas are encouraged:
-Clinical practice and management of hematological neoplasia, including: acute and chronic leukemias, malignant lymphomas, myeloproliferative disorders
-Diagnostic investigations, including imaging and laboratory assays
-Epidemiology, pathology and pathobiology of hematological neoplasia of hematological diseases
-Therapeutic issues including Phase 1, 2 or 3 trials as well as allogeneic and autologous stem cell transplantation studies
-Aspects of the cell biology, molecular biology, molecular genetics and cytogenetics of normal or diseased hematopoeisis and lymphopoiesis, including stem cells and cytokines and other regulatory systems.
Concise, topical review material is welcomed, especially if it makes new concepts and ideas accessible to a wider community. Proposals for review material may be discussed with the Editor-in-Chief. Collections of case material and case reports will be considered only if they have broader scientific or clinical relevance.